Erik Atkisson
Compliance Officer bij RAIN ONCOLOGY INC.
Vermogen: 1 120 $ op 29-02-2024
Profiel
Currently, Erik Atkisson is General Counsel & Chief Compliance Officer at Rain Oncology, Inc.
He previously held the position of Secretary & General Counsel of Eiger BioPharmaceuticals, Inc. and Chief Compliance Officer of Cytokinetics, Inc.
Erik Atkisson received an undergraduate degree from Harvard University, a graduate degree from The University of Edinburgh and a graduate degree from Georgetown University Law Center.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
26-01-2023 | 200 ( 0.01% ) | 1 120 $ | 29-02-2024 |
Actieve functies van Erik Atkisson
Bedrijven | Functie | Begin |
---|---|---|
RAIN ONCOLOGY INC. | Compliance Officer | - |
Eerdere bekende functies van Erik Atkisson
Bedrijven | Functie | Einde |
---|---|---|
EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 13-04-2023 |
CYTOKINETICS, INCORPORATED | Compliance Officer | - |
Opleiding van Erik Atkisson
Harvard University | Undergraduate Degree |
The University of Edinburgh | Graduate Degree |
Georgetown University Law Center | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CYTOKINETICS, INCORPORATED | Health Technology |
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |